PharVision Advisers’s Center Bancorp CNOB Stock Holding History

PharVision Advisers’s Portfolio CNOB Stock Details CNOB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,389	Closed	-$277K	–	296
2025 Q1	$277K	Buy	+11,389	New	+$277K	0.38%	110

Other funds holding CNOB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

PharVision Advisers's CNOB Position: Q2 2025 in Review

PharVision Advisers sold out of Center Bancorp (CNOB) in Q2 2025, closing a stake of 11,389 shares — an estimated $277K sold.

PharVision Advisers first reported a position in CNOB in Q1 2025 and held it in 1 quarter. The position peaked at $277K in Q1 2025. 184 funds tracked by Wall St. Rank hold CNOB as of Q2 2025.

PharVision Advisers reported no remaining Center Bancorp position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 11,389 Center Bancorp shares in Q2 2025, an estimated $277K.
PharVision Advisers first reported a position in Center Bancorp in Q1 2025 and held it in 1 quarter.
PharVision Advisers's Center Bancorp position peaked at $277K in Q1 2025.
184 funds tracked by Wall St. Rank held Center Bancorp as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.